<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35597797</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>24</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2058-6124</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>8</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>21</Day>
            </PubDate>
          </JournalIssue>
          <Title>Spinal cord series and cases</Title>
          <ISOAbbreviation>Spinal Cord Ser Cases</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Transient alteration of consciousness in spinal cord injury secondary to Baclofen use: a case report.</ArticleTitle>
        <Pagination>
          <StartPage>56</StartPage>
          <MedlinePgn>56</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">56</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1038/s41394-022-00511-z</ELocationID>
        <Abstract>
          <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Oral baclofen is commonly used for spasticity management, especially with neurogenic bladder in spinal cord injury (SCI). A less common side effect of baclofen is transient alterations of consciousness, which can easily be confused for altered mental status secondary to orthostatic hypotension in SCI.</AbstractText>
          <AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A 43-year-old man with an acute SCI secondary to an aortic dissection was found to have episodes of confusion after titrating oral baclofen from 5 mg three times per day to 10 mg three times per day at an acute rehabilitation facility. Orthostatic hypotension was initially suspected as the cause of transient alterations of consciousness; however, he was never found to be hypotensive during these episodes. His confusion resolved several days after discontinuation of baclofen.</AbstractText>
          <AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Although, confusion and lightheadedness in SCI are commonly caused by orthostatic hypotension, it is important for physicians to be cognizant of baclofen's side effects, which increase in the setting of acute kidney injury (AKI). If an adverse effect is suspected, baclofen should be tapered while remaining observant for signs of baclofen withdrawal, which can be life-threatening. This case report is a reminder for clinicians to be aware of the uncommon adverse effects of baclofen when initiating therapy in SCI, especially in patients with AKI and neurogenic bladders.</AbstractText>
          <CopyrightInformation>© 2022. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Pisano</LastName>
            <ForeName>Thomas John</ForeName>
            <Initials>TJ</Initials>
            <Identifier Source="ORCID">0000-0002-8432-113X</Identifier>
            <AffiliationInfo>
              <Affiliation>Icahn School of Medicine at Mount Sinai (Morningside/West), New York, NY, 10019, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ace</LastName>
            <ForeName>Jessica</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>JFK Johnson Rehabilitation Institute's Physical Medicine &amp; Rehabilitation Residency Program, Rutgers Robert Wood Johnson Medical School, Edison, NJ, 08820, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Hon</LastName>
            <ForeName>Beverly</ForeName>
            <Initials>B</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Spinal Cord Injury, Veterans Affairs New Jersey Health Care System, East Orange, NJ, 07018, USA. beverly.hon@va.gov.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Physical Medicine and Rehabilitation, Rutgers NewJersey Medical School, Newark, NJ, 07103, USA. beverly.hon@va.gov.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>F31 NS089303</GrantID>
            <Acronym>NS</Acronym>
            <Agency>NINDS NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>21</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Spinal Cord Ser Cases</MedlineTA>
        <NlmUniqueID>101680856</NlmUniqueID>
        <ISSNLinking>2058-6124</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>H789N3FKE8</RegistryNumber>
          <NameOfSubstance UI="D001418">Baclofen</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D058186" MajorTopicYN="Y">Acute Kidney Injury</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001418" MajorTopicYN="N">Baclofen</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003243" MajorTopicYN="N">Consciousness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007024" MajorTopicYN="Y">Hypotension, Orthostatic</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013119" MajorTopicYN="Y">Spinal Cord Injuries</DescriptorName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001750" MajorTopicYN="Y">Urinary Bladder, Neurogenic</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>12</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pmc-release">
          <Year>2023</Year>
          <Month>5</Month>
          <Day>21</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>23</Hour>
          <Minute>16</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>22</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35597797</ArticleId>
        <ArticleId IdType="pmc">PMC9124195</ArticleId>
        <ArticleId IdType="doi">10.1038/s41394-022-00511-z</ArticleId>
        <ArticleId IdType="pii">10.1038/s41394-022-00511-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Ghanavatian S, Derian A Baclofen. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020.</Citation>
        </Reference>
        <Reference>
          <Citation>Wuis EW, Dirks MJ, Termond EF, Vree TB, Van der Kleijn E. Plasma and urinary excretion kinetics of oral baclofen in healthy subjects. Eur J Clin Pharm. 1989;37:181–4. doi: 10.1007/BF00558228.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/BF00558228</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Simon N, Franchitto N, Rolland B. Pharmacokinetic studies of baclofen are not sufficient to establish an optimized dosage for management of alcohol disorder. Front Psychiatry. 2018;9:485. doi: 10.3389/fpsyt.2018.00485.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fpsyt.2018.00485</ArticleId>
            <ArticleId IdType="pmc">PMC6186984</ArticleId>
            <ArticleId IdType="pubmed">30349489</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knutsson E, Lindblom U, Mårtensson A. Plasma and cerebrospinal fluid levels of baclofen (Lioresal) at optimal therapeutic responses in spastic paresis. J Neurol Sci. 1974;23:473–84. doi: 10.1016/0022-510X(74)90163-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-510X(74)90163-4</ArticleId>
            <ArticleId IdType="pubmed">4154365</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf E, Kothari NR, Roberts JK, Sparks MA. Baclofen toxicity in kidney disease. Am J Kidney Dis. 2018;71:275–80. doi: 10.1053/j.ajkd.2017.07.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.ajkd.2017.07.005</ArticleId>
            <ArticleId IdType="pubmed">28899601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Su W, Yegappan C, Carlisle EJF, Clase CM. Reduced level of consciousness from baclofen in people with low kidney function. BMJ. 2009;339:b4559. doi: 10.1136/bmj.b4559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.b4559</ArticleId>
            <ArticleId IdType="pubmed">20044395</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee TH, Chen SS, Su SL, Yang SS. Baclofen intoxication: report of four cases and review of the literature. Clin Neuropharmacol. 1992;15:56–62. doi: 10.1097/00002826-199202000-00008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00002826-199202000-00008</ArticleId>
            <ArticleId IdType="pubmed">1576599</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Green LB, Nelson VS. Death after acute withdrawal of intrathecal baclofen: case report and literature review. Arch Phys Med Rehabil. 1999;80:1600–4. doi: 10.1016/S0003-9993(99)90337-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0003-9993(99)90337-4</ArticleId>
            <ArticleId IdType="pubmed">10597813</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alvis BD, Sobey CM. Oral Baclofen withdrawal resulting in progressive weakness and sedation requiring intensive care admission. Neurohospitalist. 2017;7:39–40. doi: 10.1177/1941874416637404.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1941874416637404</ArticleId>
            <ArticleId IdType="pmc">PMC5167087</ArticleId>
            <ArticleId IdType="pubmed">28042369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Illman A, Stiller K, Williams M. The prevalence of orthostatic hypotension during physiotherapy treatment in patients with an acute spinal cord injury. Spinal Cord. 2000;38:741–7. doi: 10.1038/sj.sc.3101089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.sc.3101089</ArticleId>
            <ArticleId IdType="pubmed">11175374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Albright AL. Topical review: Baclofen in the treatment of cerebral palsy. J Child Neurol. 1996;11:77–83. doi: 10.1177/088307389601100202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/088307389601100202</ArticleId>
            <ArticleId IdType="pubmed">8881981</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve Suppl. 1997;6:S92–120. doi: 10.1002/(SICI)1097-4598(1997)6+&lt;92::AID-MUS7&gt;3.0.CO;2-E.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/(SICI)1097-4598(1997)6+&lt;92::AID-MUS7&gt;3.0.CO;2-E</ArticleId>
            <ArticleId IdType="pubmed">9826984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Imbert B, Alvarez J-C, Simon N. Anticraving effect of Baclofen in alcohol-dependent patients. Alcohol Clin Exp Res. 2015;39:1602–8. doi: 10.1111/acer.12823.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/acer.12823</ArticleId>
            <ArticleId IdType="pubmed">26207768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aisen ML, Dietz MA, Rossi P, Cedarbaum JM, Kutt H. Clinical and pharmacokinetic aspects of high dose oral baclofen therapy. J Am Paraplegia Soc. 1992;15:211–6. doi: 10.1080/01952307.1992.11761520.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/01952307.1992.11761520</ArticleId>
            <ArticleId IdType="pubmed">1431867</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ragnarsson KT, Krebs M, Naftchi NE, Demeny M, Sell GH, Lowman EW, et al. Effects of head-up tilt on glomerular filtration rate and renal plasma flow in spinal man. In: Naftchi NE, editor. Spinal Cord Injury. Dordrecht: Springer Netherlands; 1982. p. 233–40.</Citation>
        </Reference>
        <Reference>
          <Citation>Chen KS, Bullard MJ, Chien YY, Lee SY. Baclofen toxicity in patients with severely impaired renal function. Ann Pharmacother. 1997;31:1315–20. doi: 10.1177/106002809703101108.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/106002809703101108</ArticleId>
            <ArticleId IdType="pubmed">9391686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ijaz M, Tariq H, Kashif M, Marquez JG. Encephalopathy and hypotonia due to baclofen toxicity in a patient with end-stage renal disease. Am J Case Rep. 2015;16:232–5. doi: 10.12659/AJCR.894206.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.12659/AJCR.894206</ArticleId>
            <ArticleId IdType="pmc">PMC4410727</ArticleId>
            <ArticleId IdType="pubmed">25895118</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dahlin PA, George J. Baclofen toxicity associated with declining renal clearance after ibuprofen. Drug Intell Clin Pharm. 1984;18:805–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6489161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kiel LB, Hoegberg LCG, Jansen T, Petersen JA, Dalhoff KP. A nationwide register-based survey of baclofen toxicity. Basic Clin Pharm Toxicol. 2015;116:452–6. doi: 10.1111/bcpt.12344.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bcpt.12344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Perry HE, Wright RO, Shannon MW, Woolf AD. Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics. 1998;101:1045–8. doi: 10.1542/peds.101.6.1045.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.101.6.1045</ArticleId>
            <ArticleId IdType="pubmed">9606233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu V-C, Lin S-L, Lin S-M, Fang C-C. Treatment of baclofen overdose by haemodialysis: a pharmacokinetic study. Nephrol Dial Transpl. 2005;20:441–3. doi: 10.1093/ndt/gfh297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/ndt/gfh297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leo RJ, Baer D. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics. 2005;46:503–7. doi: 10.1176/appi.psy.46.6.503.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/appi.psy.46.6.503</ArticleId>
            <ArticleId IdType="pubmed">16288128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peng CT, Ger J, Yang CC, Tsai WJ, Deng JF, Bullard MJ, et al.  Prolonged severe withdrawal symptoms after acute-on-chronic baclofen overdose. J Toxicol Clin Toxicol. 1998;36:359–63. doi: 10.3109/15563659809028033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/15563659809028033</ArticleId>
            <ArticleId IdType="pubmed">9711203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirubakaran V, Mayfield D, Rengachary S. Dyskinesia and psychosis in a patient following baclofen withdrawal. Am J Psychiatry. 1984;141:692–3. doi: 10.1176/ajp.141.5.692.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1176/ajp.141.5.692</ArticleId>
            <ArticleId IdType="pubmed">6711693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>D’Aleo G, Cammaroto S, Rifici C, Marra G, Sessa E, Bramanti P, et al.  Hallucinations after abrupt withdrawal of oral and intrathecal baclofen. Funct Neurol. 2007;22:81–8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17637210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cunningham JA, Jelic S. Baclofen withdrawal: a cause of prolonged fever in the intensive care unit. Anaesth Intensive Care. 2005;33:534–7. doi: 10.1177/0310057X0503300421.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0310057X0503300421</ArticleId>
            <ArticleId IdType="pubmed">16119501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrison SA, Wood CA., Jr Hallucinations after preoperative baclofen discontinuation in spinal cord injury patients. Drug Intell Clin Pharm. 1985;19:747–9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4053980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ross JC, Cook AM, Stewart GL, Fahy BG. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care. 2011;14:103–8. doi: 10.1007/s12028-010-9422-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12028-010-9422-6</ArticleId>
            <ArticleId IdType="pubmed">20717751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terrence CF, Fromm GH. Complications of baclofen withdrawal. Arch Neurol. 1981;38:588–9. doi: 10.1001/archneur.1981.00510090082011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archneur.1981.00510090082011</ArticleId>
            <ArticleId IdType="pubmed">6791618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watve SV, Sivan M, Raza WA, Jamil FF. Management of acute overdose or withdrawal state in intrathecal baclofen therapy. Spinal Cord. 2012;50:107–11. doi: 10.1038/sc.2011.112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sc.2011.112</ArticleId>
            <ArticleId IdType="pubmed">22006082</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khorasani A, Peruzzi WT. Dantrolene treatment for abrupt intrathecal baclofen withdrawal. Anesth Analg. 1995;80:1054–6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7726408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meythaler JM, Roper JF, Brunner RC. Cyproheptadine for intrathecal baclofen withdrawal. Arch Phys Med Rehabil. 2003;84:638–42. doi: 10.1016/S0003-9993(03)00105-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0003-9993(03)00105-9</ArticleId>
            <ArticleId IdType="pubmed">12736874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saissy JM, Vitris M, Demazière J, Seck M, Marcoux L, Gaye M, et al.  Flumazenil counteracts intrathecal baclofen-induced central nervous system depression in tetanus. Anesthesiology. 1992;76:1051–3. doi: 10.1097/00000542-199206000-00027.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00000542-199206000-00027</ArticleId>
            <ArticleId IdType="pubmed">1599091</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
